Select your location
group-women-sports-teams

News & Media

Take a look inside our world

Press Releases

Teva Releases Q2 2025 Aide Memoire

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-'749 (olanzapine) to Date

Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day

Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
View all press releases

Feature stories

Innovative medicine capsule with human and digital elements merging

The Future of Medicine is Now: 8 Ways Teva is Accelerating Healthcare Innovation Through AI, Advanced Devices, and Global Collaboration
Teva scientists in Sydney, Australia working in the lab

2024 Healthy Future Report: Creating the Future We Want to See

Neurological Conditions Take So Much: Teva is Working to Give Something Back

Colleagues standing in a small group discussing something while laughing. Two of the women are holding notebooks.

Diversity: A Superpower in Shaping Tomorrow’s Therapies at Teva Pharmaceuticals

Coming Home to Teva: Rediscovering Purpose and Community
little boys hugging smiling

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine
Woman using inhaler device for asthma

Medical Device Engineering: the Teva Story
Dr Beatrice Wiafe Addai addressing breast cancer meeting in Ghana

Behind the Numbers: Working to Tackle Breast Cancer in Ghana
Mark DeStefano, Director of Global Technology Innovation for the CPD R&D group at Teva

3 Trends I’m Watching in Drug Delivery Devices
Beryl Ojwang, MD, MBA, MPH, Global Associate Medical Director in Neuroscience, shares how technology helps generate patient insights for Teva scientists.

“AI helps us better understand and support patient needs”
View all stories

Contacts for Media Inquiries

Grace Ann Arnold

North America

+1-973-2653670
GraceAnn.Arnold@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com